BTG plc (LON:BTG)‘s stock had its “buy” rating reissued by equities research analysts at Numis Securities Ltd in a research report issued to clients and investors on Thursday. They currently have a GBX 900 ($11.45) price target on the stock. Numis Securities Ltd’s price target points to a potential upside of 28.21% from the company’s current price.

Other analysts have also issued research reports about the company. Panmure Gordon lowered their target price on BTG plc from GBX 809 ($10.29) to GBX 793 ($10.09) and set a “buy” rating on the stock in a report on Monday, May 22nd. Deutsche Bank AG reissued a “buy” rating and issued a GBX 775 ($9.86) target price on shares of BTG plc in a report on Thursday, May 18th. Investec reissued a “buy” rating and issued a GBX 720 ($9.16) target price on shares of BTG plc in a report on Thursday, April 6th. Stifel Nicolaus reissued a “buy” rating and issued a GBX 725 ($9.22) target price on shares of BTG plc in a report on Tuesday, April 4th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a GBX 775 ($9.86) target price on shares of BTG plc in a report on Tuesday, May 16th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of GBX 762 ($9.69).

Shares of BTG plc (LON:BTG) opened at 696.00 on Thursday. The firm’s market cap is GBX 2.68 billion. BTG plc has a 52 week low of GBX 528.36 and a 52 week high of GBX 739.50. The firm’s 50-day moving average is GBX 676.19 and its 200 day moving average is GBX 607.45.

ILLEGAL ACTIVITY NOTICE: “Numis Securities Ltd Reaffirms Buy Rating for BTG plc (BTG)” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/06/29/numis-securities-ltd-reaffirms-buy-rating-for-btg-plc-btg.html.

In related news, insider Rolf Soderstrom sold 129,514 shares of the stock in a transaction on Thursday, June 1st. The stock was sold at an average price of GBX 655 ($8.33), for a total transaction of £848,316.70 ($1,079,008.78).

BTG plc Company Profile

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Analyst Recommendations for BTG plc (LON:BTG)

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.